Close
Nordic 9Nordic 9

SkyViews Life Science (investor - Others)

Switzerland skyviewslifescience.com
See something wrong or missing? Let us know
Offices:Vevey

Skyviews Life Science is a privately held advisory company specializing in personalized health.

Average round investment:24.11M USD
Average number per year:1.7
Distribution: 2022 (2)2021 (1)2020 (2)
Portfolio companies: Switzerland Volumina MedicalUnited Kingdom Tropic BiosciencesSwitzerland Mirai Foods See the entire list
Mostly invests in: Switzerland Switzerland (2) Manufacturing (4)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SkyViews Life Science

Name Criteria
Italy Red Circle Investments
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Agriculture, Food Industry
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland ETH Zurich Foundation
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Food Industry
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Sunstone Life Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United States Invus
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services, Food Industry
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom, France
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Luxembourg Vesalius Biocapital Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Belgium Verlinvest
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Food Industry
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Norgine Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Malakoff Humanis
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Netherlands Nutreco
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Agriculture, Food Industry
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Piper Private Equity
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Food Industry
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top